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Abstract
Introduction: Reporting guidelines (e.g. CONSORT) have been developed as tools to improve quality and reduce bias in
reporting research findings. Trial registration has been recommended for countering selective publication. The International
Committee of Medical Journal Editors (ICMJE) encourages the implementation of reporting guidelines and trial registration
as uniform requirements (URM). For the last two decades, however, biased reporting and insufficient registration of clinical
trials has been identified in several literature reviews and other investigations. No study has so far investigated the extent to
which author instructions in psychiatry journals encourage following reporting guidelines and trial registration.
Method: Psychiatry Journals were identified from the 2011 Journal Citation Report. Information given in the author
instructions and during the submission procedure of all journals was assessed on whether major reporting guidelines, trial
registration and the ICMJE’s URM in general were mentioned and adherence recommended.
Results: We included 123 psychiatry journals (English and German language) in our analysis. A minority recommend or
require 1) following the URM (21%), 2) adherence to reporting guidelines such as CONSORT, PRISMA, STROBE (23%, 7%, 4%),
or 3) registration of clinical trials (34%). The subsample of the top-10 psychiatry journals (ranked by impact factor) provided
much better but still improvable rates. For example, 70% of the top-10 psychiatry journals do not ask for the specific trial
registration number.
Discussion: Under the assumption that better reported and better registered clinical research that does not lack substantial
information will improve the understanding, credibility, and unbiased translation of clinical research findings, several
stakeholders including readers (physicians, patients), authors, reviewers, and editors might benefit from improved author
instructions in psychiatry journals. A first step of improvement would consist in requiring adherence to the broadly
accepted reporting guidelines and to trial registration.
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Background
The successful translation of findings from clinical trials into
health care practice, guidelines and patient information depends
on the timely, accurate and unbiased reporting of trial method-
ology and results. The quality and reporting of clinical trials and
systematic reviews can, however, be sub-optimal. Even within the
design of RCTs, for example, there is the inherent risk of bias
skewing results at various stages and minimizing internal and
external validity [1].
First, there is empirical evidence to suggest that lack of, or
inadequate attention to, random allocation, allocation conceal-
ment, blinding and intention to treat can lead to bias [2,3].
Second, setting, participants, demographic data, co-medication
e.g. can limit the generalizability of the trial results [4,5]. There is
also increasing evidence of selective reporting in clinical trial
findings, with some recent examples in pharmacologic treatment
for depression and other psychiatric disorders [6,7,8,9].
Since the early 1990s, medical journal editors, methodologists,
and clinical researchers have developed reporting guidelines as
tools to help improve the quality of reporting in health research
articles. A reporting guideline is a checklist, flow diagram, or
explicit text to guide authors in reporting a specific type of
research, developed using explicit methodology [10]. The first
guideline, the CONSORT (CONsolidated Standards Of Report-
ing Trials) statement, was developed to improve quality of reports
on randomized controlled trials; it was first published in 1996,
revised in 2001, and updated in 2010 [11,12]. Reporting
guidelines are also available for various other study designs,
including diagnostic test accuracy studies (STAndards for Report-
ing Diagnostic accuracy, STARD) [13], observational studies
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(STrengthening the Reporting of Observational studies in
Epidemiology, STROBE) [14], Meta-analysis Of Observational
Studies in Epidemiology (MOOSE) [15], and systematic reviews of
randomized controlled trials (Preferred Reporting Items for
Systematic reviews and Meta-Analyses, PRISMA) [16].
A recent review of 134 RCTs on pharmacological treatment of
bipolar disorder published between 2000 and 2010 found that
while some trial-related information is well reported a good part of
the reporting quality of RCTs in bipolar disorder falls well below
the required level as aimed for by CONSORT [17,18]. Twenty-
five percent (n = 18) of all CONSORT items were generally
reported inadequately (reported adequately in less than 25% of all
trials). These neglected parts include essential methodological
items such as the generation of random allocation sequence
(reported in only 24% of all RCTs), method of allocation
concealment (in 22%), and all items relevant to the randomization
implementation. Also, information with essential clinical relevance
was generally reported inadequately, such as the effect size (in
22%) and the number needed to treat (16%). Other analyses of the
quality of reporting in psychiatry journals have made similar
findings [19,20,21].
The poor quality of reporting combined with the selective
reporting of trial findings undermines timely, accurate and
unbiased translation of trial results in health care practice. It has
been shown, firstly, that entire trials with primarily negative
results were not published at all (publication bias) [22]. Secondly,
it has more recently been shown that some published trials report
information selectively, with the effect of prioritizing the benefit
of a medical measure or suppressing the results concerning its
potential harm[23,24]. There is a consensus in medical research,
in publication ethics and among the leading scientific journals
that trial registration currently represents the best strategy for
countering selective publication or making it suitably transparent
[24,25,26]. Trial registers have existed since the 1960s [27]. The
most significant registries at present are ClinicalTrials.gov, run by
the National Library of Medicine (USA), which has been
accepting clinical trials outside the USA since 2005, and the
registry network of the WHO, the International Clinical Trials
Registry Platform (ICTRP), which has been in operation since
2007.
The Uniform Requirements for Manuscripts Submitted to Biomedical
Journals (URM) developed by the International Committee of Medical
Journal Editors (ICJME) [28] require, first, that authors consult
reporting guidelines relevant to their specific research design (such
as CONSORT for RCTs, or other tools that can be identified at
the website of the EQUATOR network (www.equator-network.
org) and, second, that trials are registered in a public trials registry.
While the responsibility for improvement of unbiased reporting
should primarily lie with the investigators, reviewers and journal
editors could facilitate the process by encouraging authors to
consider reporting guidelines and to register their trials. Whether
reporting guidelines are being endorsed and implemented by
medical journals has been studied for general medicine [29,30],
pediatrics and urology [31,32,33,34].
Although inadequate quality of reporting and selective reporting
of trial data have often and recently been demonstrated for
psychiatric disorders [6,7,8,9,17,19,20,21], no study has so far
investigated the extent to which author instructions in psychiatry
journals endorse reporting guidelines and trial registration as
encouraged by the URM.
This study aimed to analyze whether author instructions and
instructions during the submission procedure of psychiatry
journals mention, recommend, or require 1) the adherence to
the URM as published by the ICMJE; 2) the use of major
reporting guidelines; and 3) trial registration.
Table 1. Author instructions regarding the Uniform Requirements for Manuscripts (URM) developed by the ICMJE.








Psychiatry Journals (n = 123) 55 (45%) 42 (34%) 9 (7%) 17 (14%)
Top-10 Psychiatry Journals (n = 10) 1 (10%) - 1 (10%) 8 (80%)
doi:10.1371/journal.pone.0075995.t001
Table 2. Authors instructions regarding reporting guidelines.
















CONSORT (RCTs) 89 (72%) 6 (5%) 20 (16%) 8 (7%) 5 (50%)
PRISMA/ QUOROM (Systematic Reviews/
Meta-analyses of RCTs)
114 (93%) 1 (1%) 6 (5%) 2 (2%) 1 (10%)
STROBE (Observational studies) 117 (95%) 1 (1%) 2 (2%) 3 (2%) -
MOOSE (Systematic Reviews/ Meta-analyses
of observational studies)
117 (95%) 3 (2%) 1 (1%) 2 (2%) 1 (10%)
STARD (Diagnostic accuracy studies) 117 (95%) 2 (2%) 3 (2%) 1 (1%) 2 (20%)
doi:10.1371/journal.pone.0075995.t002
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Methods
Based on Journal Citation Reports from 2011 we identified 130
journals indexed in the subject category ‘‘psychiatry’’. We also
identified a subsample of 10 psychiatry journals with the highest
impact factor (‘‘top-10’’). We restricted our analysis to Journals
published in English or German. We accessed the ‘‘author’s
instructions’’ or similar texts on the journals’ websites between July
and August 2012. We further accessed the instructions given
during the online submission procedure in September 2012. The
online submission procedures were entered by a fake submission of
an ‘‘original paper’’ or a ‘‘clinical research’’, ‘‘clinical trial’’ paper.
All PDFs or website texts were downloaded using WinHTTrack
3.46-1 for documentation.
Two authors independently assessed whether the author
instructions mention the URM, major reporting guidelines
(CONSORT, STARD, STROBE, MOOSE, and PRISMA) and
trial registration. The QUOROM (QUality Of Reporting Of
Meta-analyses) guideline was updated and renamed PRISMA in
2009; for this analysis, we classified QUOROM as a subgroup of
PRISMA. The rating options were 1) ‘‘not mentioned’’, 2)
‘‘mentioned’’ (without specification) 3) ‘‘consideration recom-
mended’’ or 4) ‘‘consideration required’’. The rating ‘‘consider-
ation recommended’’ was applied to moderate wording in the
author instructions such as ‘‘should’’ or ‘‘we recommend that…’’.
The rating ‘‘consideration required’’ was applied to strong
wording like ‘‘authors must …’’, ‘‘we expect authors to …’’ or
‘‘we require authors to…’’.
If two or more journals referred to the same author instructions
(e.g. because of the same publisher), they were treated as
independent journals for evaluation.
We accessed the ICMJE website in September 2012 to identify
which journals are listed as following the URMs.
We calculated frequency data by standard descriptive statistics.
Results
After exclusion of 7 psychiatry journals due to language
restriction or the lack of any web page we included 123 journals
in our analysis (116 in English and 7 in German language).
Author’s instructions regarding URM and ICMJE policies
From the 123 psychiatry journals 21% (n= 26) recommend or
require following the URM and another 34% (n= 42) ‘‘only’’
mention the URM at some point in their author instructions or
during the online submission process (see table 1).
In contrast, 90% of the top-10 psychiatry journals recommend
or require adherence to ICMJE’s URMs.
Of the 123 psychiatry journals, 11 are listed on the ICMJE
website among other journals that have requested inclusion on the
list of publications that follow the ICMJE’s URMs. However, 2 of
these 11 journals mention neither reporting guidelines nor trial
registration in their author instructions or during their online
submission process.
Author’s instructions regarding reporting guidelines
The CONSORT statement, which guides the reporting of
randomized controlled trials (RCTs), was most prominently
mentioned in the journals’ author instructions (see table 2).
For all psychiatry journals 23% (n= 28) and for the top-10
psychiatry journals 50% either recommended or required
adherence to CONSORT. All other reporting guidelines were
recommended or required in 3% to 7% of all psychiatry journals
and in 0% to 20% of the top-10 psychiatry journals (see table 2).
Author’s instructions regarding trial registration
Of all 123 psychiatry journals, 34% (n= 42) and for the top-10
psychiatry journals 70% explicitly recommend or require the
authors to register clinical trials. Only 13 of these (11% of all 123
Table 3. Author instructions regarding trial registration.
Trial registration






Psychiatry Journals (n = 123) 81 (57)/66% (46%) 11 (9%) 31 (25%)
Top-10 Psychiatry Journals (n = 10) 3 (30%) - 7 (70%)
doi:10.1371/journal.pone.0075995.t003
Table 4. Comparison of findings among clinical specialties.
Policies
Clinical specialities (with percentages of journals that mentioned without specification, recommend
or require adherence to the respecting policies)
Psychiatry (n =123) Urology (n =55) [31,34] Pediatrics (n=69) [32]
ICMJE (URM) 54% 58% 55%
CONSORT 23% 24% 20%
MOOSE 3% 6% 4%
PRISMA/QUOROM 7% 5% 6%
STARD 3% 6% 6%
STROBE 4% 5% 4%
Trial Registration 34% 36% 23%
doi:10.1371/journal.pone.0075995.t004
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journals and 30% of the top-10 journals) require the registration
number during their online submission process (see table 3).
Furthermore, only 12% (n= 15) of all psychiatry journals and
60% of the top-10 journals mention specific trial registries. In total,
eleven different trial registries were mentioned with clinicaltrials.-
gov as the most prominent (n = 14).
Comparison among clinical specialities
The results for all psychiatry journals are similar to overview
findings in other specialities like paediatrics and urology that
applied assessment tools similar to those applied in this study
[31,32,33,34]. One author of this study (JM) also contributed to
the editorial policy analyses in paediatrics and urology (see table 4).
Discussion
Several internationally agreed policies and tools aim to improve
the unbiased translation of research findings into clinical practice
and health policy decision-making. Core policies and tools in this
respect are 1) the URMs (uniform requirements for manuscripts
submitted to biomedical journals) drafted by the ICMJE, 2)
reporting guidelines (e.g. CONSORT, STROBE, PRISMA)
collated by the EQUATOR network, and 3) trial registries such
as clinicaltrials.gov run by the United States National Library of
Medicine (NLM) at the National Institutes of Health or registries
certified by the WHO and working with the International Clinical
Trials Registry Platform (ICTRP).
Our main finding is that only a minority of all psychiatry
journals (n = 123) recommend or require 1) following the URM
(21%), 2) adherence to reporting guidelines such as CONSORT,
PRISMA, STROBE (23%, 7%, 4%), or 3) registration of clinical
trials (34%). While the top-10 psychiatry journals (ranked by
impact factor) highlight core recommendations and requirements
more frequently (URM=90%, CONSORT=50%, trial registra-
tion= 70%) there is still room for improvement. Beside the fact
that three top-10 journals do not recommend or require trial
registration only one top-10 journal recommends or requires
authors to follow the PRISMA statement that aims to support
reporting of systematic reviews of clinical trials.
It is obvious that authors are accountable for their manuscripts,
and it is their obligation to prepare their research articles in an
accurate, transparent, and complete manner so that all the
information important for data interpretation is available.
However, we suspect that many authors will neither know the
recommendations given in the ICMJE’s URMs, nor reporting
guidelines such as CONSORT or the practical and ethical
rationale for registering clinical trials.
One first reason for scientific journals to include information in
their author instructions about reporting guidelines and trial
registries is to help potential authors to refine the scientific strength
and impact of their publications. Authors are not only interested in
the publication of papers. Academic remits more and more refer to
how the scientific community judges the content of papers. For
example, post-publication reviews and the number of citations are
becoming more important for academic careers and grant
proposals. Nevertheless, beside the intrinsic motivation of
researchers the unbiased translation of research findings also
depends on its consistent and rigor promotion. Thus, strong
wording in editorial policies that require trial registration and the
application of reporting guidelines is necessary but not sufficient.
The adherence to such requirements should be made verifiable,
for example by requiring the inclusion of the trial registration
number in the manuscript. At present, however, 70% of the high
impact journals in Psychiatry do not ask for the specific trial
registration number.
Furthermore, it is questionable whether the peer-review process
is sufficient to guarantee completeness and accuracy of funded
research [35] and good reporting quality [31]. Because better
structured papers that do not lack substantial information can
improve readability, reviewers and readers might also benefit from
author instructions that help to improve reporting quality.
As well as authors, journals might also have an interest in
adhering to internationally agreed and broadly accepted quality
standards. We currently face controversial discussions about the
best way to organize scientific publication. Public institutions
discuss whether to sponsor open access publications. Against this
background, journals that do not support and promote basic
measures to improve the readability and credibility of publications
may struggle to remain viable in the near future. Public financing
of open access publications should require that journals which
classify for reimbursement of publication fees include information
about reporting guidelines and trial registration in their author
instructions and during their online submission process.
Independently of the personal interests of researchers and
journal editors, good science should primarily aim to decrease
biased publications of information that can negatively influence
clinical and public health decision-making. For example, the
validity of systematic reviews and meta-analyses that synthesize
findings from original studies will be undermined by biased or
poorly reported research findings. Finally, the core principles of
medicine (including the Ethics Codex of the APA) such as non-
maleficence, respect of autonomy and justice all demand greater
efforts by journal editors to improve the quality of reporting and
trial registration [36].
For the field of psychiatry, which addresses an immense patient
population with one of the world’s highest burdens of disease,
major improvements have to be made with respect to how the
majority of journals inform and require their authors to adhere to
a high quality of reporting and adequate trial registration. Our
review indicates that the top-10, high impact psychiatry journals
demonstrate more interest in high quality publications. But also
among these flagships of psychiatry journals more could be done
to enforce the registration, improve the reporting, and finally
facilitate unbiased translation of clinical research findings.
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